$AVIR Atea Pharmaceuticals, Inc. Insider Trading
Get free email notifications about insider trading in Atea Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Atea Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Atea Pharmaceuticals, Inc. for free.
CIK Number: 0001593899
IRS Number: 460574869
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AVIR
Company Address: 125 SUMMER STREET 16TH FLOOR BOSTON 02110
Phone number: 857-204-8109
Atea Pharmaceuticals, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2021 | AVIR | Atea Pharmaceutica ... | Murphy Polly A. | Director | Option Exercise | A | 23.39 | 34,025 | 795,845 | 34,025 | |
Feb 01 2021 | AVIR | Atea Pharmaceutica ... | Sommadossi Jean-Pierre | President, CEO, and ... | Option Exercise | A | 73.00 | 640,000 | 46,720,000 | 640,000 | |
Feb 01 2021 | AVIR | Atea Pharmaceutica ... | Hammond Janet MJ | Chief Development O ... | Option Exercise | A | 73.00 | 160,050 | 11,683,650 | 160,050 | |
Feb 01 2021 | AVIR | Atea Pharmaceutica ... | Corcoran Andrea | See Remarks | Option Exercise | A | 73.00 | 148,850 | 10,866,050 | 148,850 | |
Feb 01 2021 | AVIR | Atea Pharmaceutica ... | Vavricka John | Chief Commercial Of ... | Option Exercise | A | 73.00 | 117,300 | 8,562,900 | 117,300 | |
Feb 01 2021 | AVIR | Atea Pharmaceutica ... | Horga Maria Arantxa | Chief Medical Offic ... | Option Exercise | A | 73.00 | 145,500 | 10,621,500 | 145,500 | |
Feb 01 2021 | AVIR | Atea Pharmaceutica ... | Foster Wayne | See Remarks | Option Exercise | A | 73.00 | 71,750 | 5,237,750 | 71,750 | |
Feb 01 2021 | AVIR | Atea Pharmaceutica ... | Corcoran Andrea | See Remarks | Option Exercise | A | 73.00 | 148,850 | 10,866,050 | 148,850 | |
Feb 01 2021 | AVIR | Atea Pharmaceutica ... | Vavricka John | Chief Commercial Of ... | Option Exercise | A | 73.00 | 117,300 | 8,562,900 | 117,300 | |
Feb 01 2021 | AVIR | Atea Pharmaceutica ... | Horga Maria Arantxa | Chief Medical Offic ... | Option Exercise | A | 73.00 | 145,500 | 10,621,500 | 145,500 | |
Feb 01 2021 | AVIR | Atea Pharmaceutica ... | Foster Wayne | See Remarks | Option Exercise | A | 73.00 | 71,750 | 5,237,750 | 71,750 | |
Nov 05 2020 | AVIR | Atea Pharmaceutica ... | Cormorant Asset Management, LP | Option Exercise | C | 0.00 | 417,360 | 0 | 0 | ||
Nov 05 2020 | AVIR | Atea Pharmaceutica ... | Cormorant Asset Management, LP | Option Exercise | C | 0.00 | 712,250 | 0 | 0 | ||
Nov 05 2020 | AVIR | Atea Pharmaceutica ... | Cormorant Asset Management, LP | Option Exercise | C | 0.00 | 2,631,580 | 0 | 0 | ||
Nov 05 2020 | AVIR | Atea Pharmaceutica ... | Cormorant Asset Management, LP | Option Exercise | C | 0.00 | 1,650,165 | 0 | 0 |